NEWS CONTACT US CAREERS GET E-MAIL ALERTS SEARCH Home About Us Our Products Our Pipeline Immunotechnology Plasma & IVIG Medical Affairs Investors Income Statement Overview Press Releases Company Info Analyst Coverage Events & Webcasts Financial Info Stock Info SEC Filings Governance HOME INVESTORS FINANCIAL INFORMATION INCOME STATEMENT CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) 3 Months Ended 9 Months Ended Sep. 30, 2021 Sep. 30, 2020 Sep. 30, 2021 Sep. 30, 2020 REVENUES: Total revenues $ 20,680,550 $ 10,276,358 $ 54,559,758 $ 28,263,696 OPERATING EXPENSES: Cost of product revenue (exclusive of amortization expense shown below) 20,295,213 11,855,464 56,897,959 42,180,319 Research and development 770,557 1,708,391 2,917,072 4,893,549 Plasma center operating expenses 3,146,221 1,218,898 8,191,890 2,597,444 Amortization of intangible assets 178,838 178,838 536,514 536,514 Selling, general and administrative 10,726,797 9,115,744 31,198,880 25,750,458 Total operating expenses 35,117,626 24,077,335 99,742,315 75,958,284 LOSS FROM OPERATIONS (14,437,076) (13,800,977) (45,182,557) (47,694,588) OTHER INCOME (EXPENSE): Interest income 4,256 1,164 32,241 268,643 Interest expense (3,298,680) (3,091,200) (9,741,110) (8,875,597) Other income (expense) 18,546 (26,440) (106,772) (39,232) Other expense, net (3,275,878) (3,116,476) (9,815,641) (8,646,186) NET LOSS $ (17,712,954) $ (16,917,453) $ (54,998,198) $ (56,340,774) BASIC LOSS PER COMMON SHARE (in dollars per share) $ (0.13) $ (0.19) $ (0.44) $ (0.68) DILUTED LOSS PER COMMON SHARE (in dollars per share) $ (0.13) $ (0.19) $ (0.44) $ (0.68) WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: Basic (in shares) 133,770,147 87,698,258 125,682,400 82,627,753 Diluted (in shares) 133,770,147 87,698,258 125,682,400 82,627,753 Product Revenue [Member] REVENUES: Total revenues $ 20,644,842 $ 10,240,650 $ 54,452,633 $ 28,156,571 License Revenue [Member] REVENUES: Total revenues $ 35,708 $ 35,708 $ 107,125 $ 107,125 Source PDF HTML 10-Q Filing ZIP XLS HTML XBRL PUBLISHED: NOVEMBER 10, 2021 About Us Our Products Our Pipeline Inmunotechnology Plasma & IVIG Medical Affairs Investors Privacy Policy Disclaimer Sitemap Contact Us Connect with Us Email Alerts RSS © Copyright 2021 ADMA Biologics, Inc. Ramsey, NJ Offices 201-478-5552 Boca Raton, FL Offices 561-989-5800 info@admabio.com 2020 INNOVATOR AWARD NAMED 2019 COMPANY OF THE YEAR